Enlarged vestibular aqueduct (EVA) is one of the most common inner ear anomalies associated with sensorineural hearing loss (SNHL) in childhood. OBJECTIVE: This study aimed to investigate the prevalence of EH in patients with large vestibular aqueduct syndrome (LVAS).
Clinicians managing EVA patients should be aware of possible concurrent endolymphatic hydrops as a contributor to fluctuating hearing loss, though treatment protocol changes require confirmation from larger prospective studies.
Identifying a structural–pathophysiological link between EVA and endolymphatic hydrops could open new diagnostic and management pathways for pediatric and adult patients with this common inner-ear anomaly.
- 01Investigates co-occurrence of enlarged vestibular aqueduct (EVA) and endolymphatic hydrops.
- 02EVA is one of the most common identifiable causes of childhood sensorineural hearing loss.
- 03Endolymphatic hydrops (excess inner-ear fluid pressure) may explain fluctuating hearing in EVA patients.
- 04Published in Acta Otolaryngologica, a peer-reviewed otology journal.
- 05Findings could influence diagnostic workup for EVA, potentially including hydrops imaging.
Enlarged vestibular aqueduct can co-occur with endolymphatic hydrops.
studypartially supported- PMID
- 42115145
- DOI
- 10.1080/00016489.2026.2668688.
- Journal
- Acta Otolaryngologica
- Publication type
- research_article
- Evidence level
- 4
- Population
- Patients with enlarged vestibular aqueduct (EVA), likely including pediatric and adult cases
- Intervention
- Diagnostic investigation of endolymphatic hydrops in EVA patients
Primary outcomes
Prevalence of endolymphatic hydrops in patients with enlarged vestibular aqueduct